Availability of Targets. Merck may designate up to six (6) Targets under this Agreement as follows: The [*] Target are the Named Targets set forth in the Collaboration Agreement. Merck may designate a [*] Additional Target as Accepted Targets in accordance with Sections 2.5 and 2.6 within [*] months from the Effective Date (“Target Nomination Date”). Merck may designate a [*] Additional Target as Accepted Targets in accordance with Sections 2.5 and 2.6 at any time following the Target Nomination Date until [*] months from the Effective Date at the latest. All such Additional Targets that become Accepted Targets will be set forth on Schedule 1.1.
Appears in 2 contracts
Samples: License Agreement, License Agreement (Sutro Biopharma Inc)
Availability of Targets. Merck may designate up to six (6) Targets under this Agreement as follows: The [*] Target are the Named Targets set forth in the Collaboration Agreement. Merck may designate a [*] Additional Target as Accepted Targets in accordance with Sections 2.5 and 2.6 within at any time prior to [*] months from the Effective Date (“Target Nomination Date”)]. Merck may designate a [*] Additional Target as Accepted Targets in accordance with Sections 2.5 and 2.6 at any time following the Target Nomination Date until [*] months from the Effective Date at the latest]. All such Additional Targets that become Accepted Targets will be set forth on Schedule 1.1.
Appears in 2 contracts
Samples: License Agreement, License Agreement (Sutro Biopharma Inc)